Gabapentin Capsule
Product Images NDC 71335-2741

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

This formula calculates the creatinine clearance rate in patients by factoring in their age, weight, and serum creatinine level. For female patients, the result is multiplied by 0.85.*

FDA Label Image

Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

The provided text seems to mention a pain score of 10, a dose titration period of 4 weeks, followed by a fixed dose period. The treatment mentioned includes Gabapentin at a dose of 3600 mg/day. The text indicates the use of a placebo as well. This could be related to a study or a clinical trial evaluating the effectiveness of Gabapentin on pain relief.*

FDA Label Image

Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

FDA Label Image

Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

This text presents data on the proportion of responders in controlled postherpetic neuralgia (PHN) studies, with patients who experienced more than a 50% reduction in pain score at the endpoint. The comparison is shown for Study 1 and Study 2, indicating response rates of 32% and 34%. Additionally, there are mentions of GBP values (e.g., GBP 3600, PBO, GBP 1800, GBP 2400) associated with the studies, suggesting a financial or currency-related aspect in the evaluation.*

FDA Label Image

Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

FDA Label Image

Label (Lbl713352741)

This is a package insert for Gabapentin capsules containing 100 mg each. The usual dosage information and storage instructions are provided. It also emphasizes keeping the medication out of reach of children and using a tight, light-resistant container with a child-resistant closure for dispensing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.